FEBRUARY 20, 2012

Browse Categories

ASCO 2008 Annual Meeting - A Randomized Phase II Trial of Sorafenib Versus Sorafenib Plus Low-Dose Interferon-Alfa: Clinical Results and Biomarker Analysis

Wed, 13 August 2008
E-mail Print

Abstract No.: 5093
Citation: J Clin Oncol 26: 2008 (May 20 suppl; abstr 5093)
Author(s): N. M. Tannir, A. J. Zurita, J. V. Heymach, H. T. Tran, L. C. Pagliaro, P. Corn, A. M. Aparicio, R. Ashe, J. J. Wright, E. Jonasch




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |